about
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio...
Read More
11.20
-0.02
(-0.18%)
58,482
XNAS Volume
XNAS 13 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Korro Bio Inc is on 20 May 2026 for the purpose of 2026 RBC Capital Markets Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Bearish
Korro Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..